These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11763476)

  • 1. Effects of adhesives and permeation enhancers on the skin permeation of captopril.
    Park ES; Chang SJ; Rhee YS; Chi SC
    Drug Dev Ind Pharm; 2001 Oct; 27(9):975-80. PubMed ID: 11763476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of crystallization in drug-in-adhesive-type transdermal patches.
    Jain P; Banga AK
    Int J Pharm; 2010 Jul; 394(1-2):68-74. PubMed ID: 20438819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeation Studies of Captopril Transdermal Films Through Human Cadaver Skin.
    Nair RS; Nair S
    Curr Drug Deliv; 2015; 12(5):517-23. PubMed ID: 25675336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of pressure-sensitive adhesives and solubilizers on the skin permeation of testosterone from a matrix-type transdermal delivery system.
    Zhao H; Park DW; Kim SK; Lee CH; Kim DD
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1125-31. PubMed ID: 12455471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols.
    Kanikkannan N; Singh M
    Int J Pharm; 2002 Nov; 248(1-2):219-28. PubMed ID: 12429475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of transdermal permeation of captopril by iontophoresis.
    Wang H; Hou HM
    Acta Pharmacol Sin; 2000 Jul; 21(7):591-5. PubMed ID: 11360663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption.
    Gullick DR; Pugh WJ; Ingram MJ; Cox PA; Moss GP
    Drug Dev Ind Pharm; 2010 Aug; 36(8):926-32. PubMed ID: 20184419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of solvents on skin permeation of formoterol fumarate.
    Kakubari I; Nakamura N; Takayasu T; Yamauchi H; Takayama S; Takayama K
    Biol Pharm Bull; 2006 Jan; 29(1):146-9. PubMed ID: 16394528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro evaluation of pentazocine transdermal delivery system.
    Furuishi T; Io T; Fukami T; Suzuki T; Tomono K
    Biol Pharm Bull; 2008 Jul; 31(7):1439-43. PubMed ID: 18591789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and in vitro evaluation of transdermal patches of melatonin.
    Kanikkannan N; Andega S; Burton S; Babu RJ; Singh M
    Drug Dev Ind Pharm; 2004 Feb; 30(2):205-12. PubMed ID: 15089055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
    Pfister WR; Hsieh DS
    Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation optimization and stability study of transdermal therapeutic system of nicorandil.
    Tipre DN; Vavia PR
    Pharm Dev Technol; 2002; 7(3):325-32. PubMed ID: 12229264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesizing the Oleic Acid-Mediated Enhanced and Sustained Transdermal Codelivery of Pregabalin and Diclofenac Adhesive Nanogel: A Proof of Concept.
    Datta D; Noor A; Rathee A; Singh S; Kohli K
    Curr Mol Med; 2024; 24(11):1317-1328. PubMed ID: 38847251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel soft hydrogel for the transdermal delivery of testosterone.
    An NM; Kim DD; Shin YH; Lee CH
    Drug Dev Ind Pharm; 2003 Jan; 29(1):99-105. PubMed ID: 12602497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.